Valvectomy Versus Replacement for the Surgical Treatment of Tricuspid Endocarditis

The Annals of Thoracic Surgery
Adam N ProtosMark S Slaughter

Abstract

Optimal surgical treatment of infective tricuspid endocarditis is debatable, especially in the setting of inherent social and pathologic concerns. This study compared tricuspid valve repair, replacement, and excision for the treatment of infective endocarditis METHODS: A single-center cardiac surgery database was queried to identify patients aged older than 18 years who underwent tricuspid valve operations for infective endocarditis between 2012 and 2016. Patients were divided into three groups by the type of tricuspid valve operation: valvectomy, repair, or replacement. Patients were evaluated to identify differences between preoperative factors and outcomes, including death, length of stay, and complications. During the study period, 63 patients underwent surgical treatment of infective tricuspid valve endocarditis. Demographic and baseline characteristics were comparable across all groups, except that the valve repair group was older compared with valvectomy and replacement (46 vs 29 and 31 years, respectively; p = 0.007), with more hypertension, elevated creatinine, and a lower incidence of diffuse, bilateral pulmonary emboli. Staphylococcus species were the most common organisms. The incidence of death, bleeding requiring ...Continue Reading

Citations

Aug 28, 2020·Seminars in Cardiothoracic and Vascular Anesthesia·Jasdeep S DhaliwalKevin W Hatton
Nov 28, 2020·Expert Review of Cardiovascular Therapy·Ana Paula TagliariMaurizio Taramasso
Dec 23, 2019·The Journal of Thoracic and Cardiovascular Surgery·Mark S SlaughterJaimin R Trivedi
Feb 3, 2020·The Journal of Thoracic and Cardiovascular Surgery·Siamak Mohammadi, Dimitri Kalavrouziotis
Jan 1, 2019·Operative Techniques in Thoracic and Cardiovascular Surgery : a Comparative Atlas : an Official Publication of the American Association for Thoracic Surgery·Alexander A BresciaSteven F Bolling
Mar 25, 2019·The Journal of Thoracic and Cardiovascular Surgery·Aaron J Weiss, Anelechi C Anyanwu
Aug 7, 2021·The American Journal of Cardiology·Agam BansalAllan L Klein

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Revista brasileira de cirurgia cardiovascular : órgão oficial da Sociedade Brasileira de Cirurgia Cardiovascular
Maurício Nassau MachadoLilia Nigro Maia
Innovations : Technology and Techniques in Cardiothoracic and Vascular Surgery
William T BurkeKendra J Grubb
© 2022 Meta ULC. All rights reserved